Cargando…

Comparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A meta-analysis of randomized controlled trials

Previous studies have shown that the combination of cilostazol and aspirin may be a more effective regimen than ticlopidine plus aspirin in the prevention of late restenosis and acute or subacute stent thrombosis following coronary stenting; however, individually published results are inconclusive....

Descripción completa

Detalles Bibliográficos
Autores principales:	HU, FENG-HUAN, YI, XIN, YANG, YUE-JING, QIAO, SHU-BIN, WU, YONG-JIAN, YUAN, JIAN-SONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786799/ https://www.ncbi.nlm.nih.gov/pubmed/24137273 http://dx.doi.org/10.3892/etm.2013.1190

Ejemplares similares

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
por: Ikushima, Ichiro, et al.
Publicado: (2011)

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
por: Chung, Jong-Won, et al.
Publicado: (2019)

Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
por: Berger, Peter B
Publicado: (2000)

Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
por: Montalto, Massimo, et al.
Publicado: (2011)

Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.
por: Ahn, Jeong Cheon, et al.
Publicado: (2004)

Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation
por: Liu, Hui, et al.
Publicado: (2023)

Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials
por: Huang, Feng
Publicado: (2018)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Efficacy of Cilostazol on Uncontrolled Coronary Vasospastic Angina: A Pilot Study
por: Yoo, Sang-Yong, et al.
Publicado: (2013)

Severe aplastic anemia induced by ticlopidine: report of two cases.
por: Bahng, H., et al.
Publicado: (1998)

Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report
por: Previtera, Antonino M, et al.
Publicado: (2010)

Spontaneous retroperitoneal hematoma associated with combined warfarin and ticlopidine use
por: Ulubay, Mahmut
Publicado: (2018)

Treatment of In-Stent Stenosis Following Flow Diversion of Intracranial Aneurysms with Cilostazol and Clopidogrel
por: Dowlati, Ehsan, et al.
Publicado: (2021)

Cilostazol combined with P2Y(12) receptor inhibitors: A substitute antiplatelet regimen for aspirin‐intolerant patients undergoing percutaneous coronary stent implantation
por: Zhao, Yikai, et al.
Publicado: (2022)

Is the interaction between ticlopidine and cyclosporin dose related? Report of three cases
por: Houssaïni, Tarik Sqalli, et al.
Publicado: (2010)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease
por: Lee, Seung-Pyo, et al.
Publicado: (2010)

Detection of Clopidogrel Hyporesponsiveness Using a Point-of-Care Assay and the Impact of Additional Cilostazol Administration after Coronary Stent Implantation in Diabetic Patients
por: Yang, Tae-Hyun, et al.
Publicado: (2011)

Polymer-free versus permanent polymer drug eluting stents in coronary artery disease: A meta-analysis of 10 RCTs with 6575 patients
por: Wu, De-Wei, et al.
Publicado: (2016)

Ticlopidine in Its Prodrug Form Is a Selective Inhibitor of Human NTPDase1
por: Lecka, Joanna, et al.
Publicado: (2014)

Acceptance of Combined Coronary CT Angiography and Myocardial CT Perfusion versus Conventional Coronary Angiography in Patients with Coronary Stents—Intraindividual Comparison
por: Rief, Matthias, et al.
Publicado: (2015)

Coronary artery bypass grafting versus stents
por: Iglézias, JCR, et al.
Publicado: (2013)

Effect of Pioglitazone on In-Stent Restenosis after Coronary Drug-Eluting Stent Implantation: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ming-duo, et al.
Publicado: (2014)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes: a meta-analysis
por: Qiao, Yanxiang, et al.
Publicado: (2013)

Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome
por: Ma, Yuan-Liang, et al.
Publicado: (2018)

Clinical Outcomes Following Simple or Complex Stenting for Coronary Bifurcation Lesions: A Meta-Analysis
por: Zhang, Qun, et al.
Publicado: (2022)

Randomized Comparison of the Crush Versus the Culotte Stenting for Coronary Artery Bifurcation Lesions
por: Zheng, Xu-Wei, et al.
Publicado: (2016)

Effect of Probucol and/or Cilostazol on Carotid Intima Media Thickness in Patients with Coronary Heart Disease: A Randomized, Multicenter, Multinational Study
por: Kang, Hyun-Jae, et al.
Publicado: (2021)

Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
por: Ni, Le, et al.
Publicado: (2020)

Effects of cilostazol on the heart rate in healthy dogs
por: FUKUSHIMA, Ryuji, et al.
Publicado: (2018)

The Effect of Cilostazol on Endothelial Function as Assessed by Flow-Mediated Dilation in Patients with Coronary Artery Disease
por: Mori, Hiroyoshi, et al.
Publicado: (2016)

Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary intervention
por: Zheng, Jian-Feng, et al.
Publicado: (2020)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2008)

Serial coronary computed tomography angiography-verified coronary plaque progression: comparison of stented patients with or without diabetes
por: Shi, Rui, et al.
Publicado: (2019)

Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
por: Liu, Lulu, et al.
Publicado: (2018)

Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions
por: Yin, Dong, et al.
Publicado: (2017)

A Randomized Study Assessing the Effects of Pretreatment with Cilostazol on Periprocedural Myonecrosis after Percutaneous Coronary Intervention
por: Kim, Byeong-Keuk, et al.
Publicado: (2011)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pquvsehf82lfcbq50kugj7ntcj